Johannes Ermert (Bernd Neumaier)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 5

Top Topics

Ankylosing Spondylitis

Structural Basis

Top Venues

Journal of labelled compounds & radiopharmaceuticals

Translational psychiatry

ACS medicinal chemistry letters

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Roberta Cologni, Marcus Holschbach, Daniela Schneider, Dirk Bier, Annette Schulze, Carina Stegmayr, Heike Endepols, Johannes Ermert, Felix Neumaier, Johannes Ermert
Preparation and Preclinical Evaluation of 18 F-Labeled Olutasidenib Derivatives for Non-Invasive Detection of Mutated Isocitrate Dehydrogenase 1 (mIDH1). Molecules (Basel, Switzerland) 29 (16) (2024)
Ravichandran Rajkumar, Cláudia Régio Brambilla, Tanja Veselinović, Joshua Bierbrier, Christine Wyss, Shukti Ramkiran, Linda Orth, Markus Lang, Elena Rota Kops, Jörg Mauler, Jürgen Scheins, Johannes Ermert, Johannes Ermert, Hans Herzog, Karl-Josef Langen, Ferdinand Christoph Binkofski, Christoph W Lerche, N Jon Shah, Irene Neuner
Excitatory-inhibitory balance within EEG microstates and resting-state fMRI networks: assessed via simultaneous trimodal PET-MR-EEG imaging. Translational psychiatry 11 (1) (2021)
Michael Willmann, Julian Hegger, Johannes Ermert, Johannes Ermert
Radiosynthesis and Biological Evaluation of [18F]R91150, a Selective 5-HT2A Receptor Antagonist for PET-Imaging. ACS medicinal chemistry letters 12 (5) (2021)
Johannes Ermert, Johnny Castillo Meleán, Swen Humpert, Daniel Modemann, Dominik Krupp, Isabel Kern, Sabrina Kreft, Heinz H Coenen
Baeyer-Villiger oxidation tuned to chemoselective conversion of non-activated [18 F]fluorobenzaldehydes to [18 F]fluorophenols. Journal of labelled compounds & radiopharmaceuticals 62 (8) (2020)
Johannes Ermert
Labelling with positron emitters of pnicogens and chalcogens. Journal of labelled compounds & radiopharmaceuticals 61 (3) (2017)